Business headlines from the Apex backend, organized by sectors and major public companies for faster market scanning.
A Yahoo Finance recap summarizes CVS Health’s Q2 2026 earnings call, but provides limited detail on specific operating metrics in the information reviewed for this report.
THE APEX TIMES
THE APEX TIMES
Palantir reported a fast-growing quarter with revenue up 93% year over year, U.S. commercial sales up 149% and government revenue up 90%, according to a market report published Tuesday.
THE APEX TIMES
The Massachusetts senator said routine use of services such as Meta’s Instagram and Google’s Gmail may be helping power artificial intelligence, and she urged that the public receive a broader share of the benefits.
THE APEX TIMES
A new round of “value” messaging at McDonald’s is being met with lukewarm response from diners, with a market-news report pointing to a sales slump and suggesting the latest deal strategy is not winning back enough traffic.
THE APEX TIMES
CVS Health reported second-quarter net income of $2.9 billion, nearly tripling from the year-ago period, citing improvements in how it is managing costs tied to its Aetna health plan.
THE APEX TIMES
The software company increased its 2026 revenue, profit, and cash flow targets, citing stronger demand for AI-related deployments. The update outlines higher execution expectations for a company whose results often hinge on large commercial and government contract deployments.
THE APEX TIMES
A push in GE Aerospace’s commercial engines business, driven by aftermarket services and spare parts alongside LEAP-related delivery momentum, is supporting management’s longer growth framing for 2026, according to a recent Yahoo Finance market report.
THE APEX TIMES
A recent rally has pushed Palantir’s stock up sharply over roughly a month, with market commentary pointing to improving profitability and cash generation alongside AI-focused demand. The next test for the shares will be whether results can keep pace with expectations.
THE APEX TIMES
A new market note argues that UnitedHealth’s stock upside hinges less on growth and more on narrowing the gap between revenue performance and operating margin.
